Evidence map›Paper›PMID 32420177›Full record

ReviewTranslational andrology and urology2020

Development of nanotechnology in andrology.

Sheng-Zhuo Liu, De-Chao Feng, Zhi-Hong Liu, Jia-Yu Liang, Zheng-Ju Ren, Chuan Zhou, Kan Wu, Fu-Xun Zhang, Fan Zhang, Yi-Ping Lu and 1 more

Abstract readReview
In one paragraph

Review in Translational andrology and urology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sheng-Zhuo LiuDepartment of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China.
De-Chao FengDepartment of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China.
Zhi-Hong LiuDepartment of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China.
Jia-Yu LiangDepartment of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China.
Zheng-Ju RenDepartment of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China.
Chuan ZhouDepartment of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China.
Kan WuDepartment of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China.
Fu-Xun ZhangDepartment of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China.
Fan ZhangDepartment of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China.
Yi-Ping LuDepartment of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China.
Xian-Ding WangDepartment of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since first introduced in 1980s, nanotechnology has always been the eye-catching point as its providing us with new approaches to explore the microscopic world. Many nanotechnology-associated novel technologies have been brought into clinical use in the past decades and uncountable patients benefited from them, which convinces us of a bright prospect of nanotechnology in the field of medicine. In this review, literatures concerning nanotechnology applications in andrology were retrieved and we made a comprehensive discussion on drug delivery, gene therapy and stem cell therapy use in andrology, which calls for the engagement of nanotechnology.

Indexed as

erectile dysfunction (ED)nanoparticleNanotechnologypremature ejaculation (PE)

Identifiers

PMID32420177
PMCPMC7214986

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.